Impediments to the Successful Use of Anabolic Agents in Clinical Care

Journal of Parenteral and Enteral Nutrition

Volumn 23, Issue 6_suppl, 1999, Pages S210-S213

  Wilmore, Douglas W ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; GROWTH FACTOR; RECOMBINANT GROWTH HORMONE;

CONFERENCE PAPER; DRUG SAFETY; HUMAN; INFLAMMATION; MEDICAL CARE; MULTICENTER STUDY (TOPIC); NONHUMAN; NUTRIENT; NUTRITIONAL STATUS; PATIENT CARE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; TREATMENT RESPONSE; BURN; CLINICAL TRIAL; DRUG COST; DRUG EFFECT; HEPATITIS; HORMONAL THERAPY; TREATMENT INDICATION; WASTING SYNDROME;

DRUG COSTS; GROWTH SUBSTANCES; HUMAN GROWTH HORMONE; HUMANS; INFLAMMATION; NUTRITION DISORDERS; TREATMENT OUTCOME;

EID: 0032752168     PISSN: 01486071     EISSN: 19412444     Source Type: Journal    
DOI: 10.1177/014860719902300607     Document Type: Conference Paper

References (28)

1. Herndon DN, Barrow RE, Kunkel KR, et al. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 212: 424-429, 1990
2. Ramirez RJ, Wolf SE, Barrow RE, et al. Growth hormone treatment in pediatric burns: A safe therapeutic approach. Ann Surg 228: 439-448, 1998
3. Ziegler TR, Young LS, Ferrari-Baliviera E., et al. Use of human growth hormone combined with nutritional support in a critical care unit. JPEN 14: 574-581, 1990
4. Jiang ZM, He GZ, Zhang SY, et al. Low-dose growth hormone and hypocaloric nutrition attenuate the protein-catabolic response after major operation. Ann Surg 210: 513-524, 1989
5. Hammarqvist F., Stromberg C., von-der-Decken A., et al. Biosynthetic human growth hormone preserves both muscle protein synthesis and the decrease in muscle-free glutamine, and improves whole-body nitrogen economy after operation. Ann Surg 216: 184-191, 1992
6. Mjaaland M., Unneberg K., Larsson J., et al. Growth hormone after abdominal surgery attenuated forearm glutamine, alanine, 3-methylhistidine, and total amino acid efflux in patients receiving total parenteral nutrition. Ann Surg 217: 413-422, 1993
7. Byrne TA, Morrissey TB, Gatzen C., et al. Anabolic therapy with growth hormone accelerates protein gain in surgical patients requiring nutritional rehabilitation. Ann Surg 218: 400-418, 1993
8. Manson, JM, Wilmore DW: Positive nitrogen balance with human growth hormone and hypocaloric intravenous feedings. Surgery 100: 188-197, 1986
9. Ward HC, Halliday D., Sim AJM: Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 206: 56-61, 1987
10. Wilmore DW, Lacey JM, Soultanakis RP, et al. Factors predicting a successful outcome after pharmacologic bowel compensation. Ann Surg 226: 288-293, 1997
11. Scolapio JS Camilleri M. Fleming CR, et al. Effect of growth hormone. glutamine and diet on adaptation in short bowel syndrome: A randomized. controlled study. Gastroenterology 113: 1074-1081. 1997
12. Tayek JA Brasel JA: Failure of anabolism in malnourished cancer patients receiving growth hormone: A clinical research center study. J Clin Endocrinol Metal 80: 2082-2087. 1995
13. McNurlan MA Garlick PJ Steigbigel RT, et al. Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease. J Clin Invest 100: 2125-2132. 1997
14. Scolapio JS: Effect of growth hormone, glutamine and diet on body composition in short bowel syndrome: A randomized controlled study (Abstr). JPEN 23: S2, 1999
15. Jensen MB, Kissmeyer-Nielsen P., Laurberg S.: Periooperative growth hormone treatment increases nitrogen and fluid balance and results in short-Term and long-Term conservation of lean tissue mass. Am J Clin Nutr 1998, 68: 840-846
16. Burdet L., de Muralt B., Schotz Y., et al. Administration of growth hormone to underweight patients with chronic obstruction pulmonary disease. A prospective randomized controlled trial. Am J Resp Crit Care Med 156: 1800-1806, 1997
17. Ellegard L., Bosaeus I., Nordgren S., et al. Low-dose recombinant human growth hormone increases body weight and lean body mass in patients with short bowel syndrome. Ann Surg 225: 88-96, 1997
18. Thissen JP, Ketelslegers JM, Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocr Rev 15: 80-101, 1994
19. Droke EA, Spears JW, Armstrong JD, et al. Dietary zinc affects serum concentrations of insulin and insulin-like growth factor-1 in growing lambs. J Nutr 123: 13-19, 1993
20. Ninh NX, Thissen J-P., Maiter D., et al. Reduced liver insulin-like growth factor-1 gene expression in young zinc-deprived rats associated with a decrease in liver growth hormone (GH) receptors and serum GH-binding protein. J Endocrinol 144: 449-456, 1995
21. Clegg MS, Donovan SM, Monaco MH, et al. The influence of manganese deficiency on serum IGF-1 and IGF binding proteins in the male rat. Proc Soc Exp Biol Med 219: 41-47, 1998
22. Geerling BJ, Badart-Smook A., et al. Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr 67: 919-926, 1998
23. Burnes JU, O'Keefe SJ, Fleming CR, et al. Home parenteral nutrition: A 3 year analysis of clinical and laboratory monitoring. JPEN 16: 327-332, 1992
24. Ross RJM, Chew SL: Acquired growth hormone resistance. Eur J Endocrinol 132: 655-660, 1995
25. Knox JB, Wilmore DW, Demling RH, et al. Use of growth hormone for postoperative respiratory failure. Am J Surg 171: 576-580, 1996
26. Knox J., Demling R., Wilmore D., et al. Increased survival after major thermal injury: The effect of growth hormone in adults. J Trauma 39: 526-530, 1995
27. Takala J., Ruokonen E., Webster NR, et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Eng J Med 341: 785-792, 1999
28. Drake W., Coyte D., Camacho-Hubner C., et al. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults. J Clin Endocrinol Metab 83: 3913-3919, 1998